Moderna stock costs EUR 173.65 with a P/ E of minus 24.4

Published on 10/08/2026 at 19:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EUR 173.65 was the price on October 8, 2026 versus EUR 174.75 before. Moderna stock stood 0.63 percent below its prior close in late trading.

Key points in brief

Moderna stock stood at EUR 173.65 at Lang & Schwarz on October 8, 2026, 0.63 percent below its EUR 174.75 prior close.
The Nasdaq quote was USD 194.56, with a USD 22.28 to USD 212.22 52-week range.
Moderna had a USD 77.2 billion market capitalization and a negative P/E of 24.4.
Trading volume reached 8,055,842 shares versus an average of 17,438,279.

Aquarellmalerei der Cambridge-Skyline mit modernen Forschungsgebäuden am Charles River — Moderna Inc. (US60770K1034) präsentiert eine stimmungsvolle Aquarell-Ansicht der Cambridge-Skyline mit modernen Biotech-Forschungsgebäuden am Flussufer, Illustration mit AI erstellt.

Moderna Inc. (ISIN US60770K1079) stood at EUR 173.65 at Lang & Schwarz on October 8, 2026 at 7:42 p.m. CEST, 0.63 percent below the prior close of EUR 174.75. The after-hours quote puts the focus on valuation and the stock's distance from its yearly high rather than on a fresh corporate announcement.

Price sits below yearly high

On Nasdaq, Moderna was last at USD 194.56 on October 8, 2026 at 1:52 p.m. ET. The US quote places the stock 8.3 percent below its 52-week high of USD 212.22 and well above the 52-week low of USD 22.28.

Trading volume stood at 8,055,842 shares, versus an average of 17,438,279 shares. That is 53.8 percent below the average, giving the session a lower-volume profile than the recent norm.

Valuation and analyst target

Moderna's market capitalization was USD 77.2 billion on October 8, 2026, while its price-to-earnings ratio was minus 24.4. The company does not carry a trailing dividend yield in the quoted figures.

MarketBeat reported on October 7, 2026 that Morgan Stanley raised its Moderna target to USD 95.00 from USD 89.00 and kept an Equal Weight rating. The USD 95.00 target is 51.2 percent below the Nasdaq price of USD 194.56.

Comparison with peers

Moderna Inc.: minus 0.63 percent, P/E minus 24.4, market capitalization USD 77.2 billion

BioNTech (Nasdaq, USD): minus 2.58 percent, P/E minus 12.3, market capitalization USD 23.3 billion

Gilead Sciences (Nasdaq, USD): minus 0.38 percent, P/E minus 54.8, market capitalization USD 181.4 billion

Price and valuation snapshot

Moderna's euro quote was EUR 173.65 at Lang & Schwarz on October 8, 2026 at 7:42 p.m. CEST, compared with the EUR 174.75 prior close. The bid was EUR 173.38 and the ask was EUR 173.92, while the Nasdaq quote was last at USD 194.56 at 1:52 p.m. ET.

The further course of trading is shown by the continuously updated real-time quote of Moderna stock.